July 25, 2016 2:34 PM ET

Healthcare Equipment and Supplies

Company Overview of Cordis Corporation

Company Overview

Cordis Corporation develops interventional medical devices for cardiovascular, endovascular, and biliary duct (liver) treatments. It provides guiding and diagnostic catheters, guidewires, sheath introducers, carotid stent systems, vena cava filters, transhepatic biliary stents, and other devices and accessories. Cordis Corporation was formerly known as Medical Development Corporation and changed its name to Cordis Corporation in 1959. The company was founded in 1957 and is headquartered in Fremont, California. As of October 4, 2015, Cordis Corporation operates as a subsidiary of Cardinal Health, Inc.

6500 Paseo Padre Parkway

Fremont, CA 94555

United States

Founded in 1957

3,620 Employees



Key Executives for Cordis Corporation

Vice President of Worldwide Clinical Research & Operations
President of Worldwide
Vice President of Regulatory Affairs and Quality Assurance
Age: 68
Vice President of Latin American Operations
Age: 87
Vice President of Corporate Relations and Assistant Secretary
Age: 79
Compensation as of Fiscal Year 2016.

Cordis Corporation Key Developments

QT Vascular Ltd. Signs Amendment to Distribution Agreement with Cordis Corporation

QT Vascular Ltd. announced that it has signed an amendment to its distribution agreement with Cordis Corporation. The revised distribution agreement with Cordis allows the Group to sell the Chocolate® PTA balloon catheter to a select group of 88 healthcare providers in the United States effective immediately. Prior to the amendment, Cordis was the sole distributor of the Group's Chocolate® PTA balloon catheter in the United States. This change supports the Group's goal of increasing the adoption and use of Chocolate® PTA in the United States. The Group expects the distribution relationship with Cordis to continue to be collaborative and productive.

Wi-Lan Inc. Enters into Settlement, License Agreement with Codman & Shurtleff, Cordis Corporation

Wi-Lan (WILN) announced that it has entered into a settlement and license agreement with Codman & Shurtleff, Inc. and Cordis Corporation resolving the patent litigation that was pending in the United States District Court for the Central District of California.

Back Bay Medical Inc., Enters into Settlement and License Agreement with Codman & Shurtleff, Inc. and Cordis Corporation

WiLAN announced that the company's subsidiary, Back Bay Medical Inc., has entered into a settlement and license agreement with Codman & Shurtleff, Inc. and Cordis Corporation. The agreement resolves litigation that was pending in the United States District Court for the Central District of California.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cordis Corporation, please visit www.cordis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.